Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide). (Q53073221)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 2014

Language	Label	Description	Also known as
English	Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide).	scientific article published in April 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide). (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

1 reference

based on heuristic

inferred from title

author name string

R T Morris

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

R N Joyrich

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

R W Naumann

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

N P Shah

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

A H Maurer

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

H W Strauss

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

J M Uszler

7

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

J T Symanowski

8

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

P R Ellis

9

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

W A Harb

10

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

publication date

1 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

25

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

852-858

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDU024

21 January 2018

Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDU024

21 January 2018

Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDU024

21 January 2018

Exploitation of the folate receptor in the management of cancer and inflammatory disease

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDU024

21 January 2018

Human reduced folate carrier: translation of basic biology to cancer etiology and therapy

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDU024

21 January 2018

Comparative preclinical activity of the folate-targeted Vinca alkaloid conjugates EC140 and EC145.

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDU024

21 January 2018

Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDU024

21 January 2018

Exploratory study of 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors.

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDU024

21 January 2018

Identifiers

10.1093/ANNONC/MDU024

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24667717

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53073221&oldid=1800762773"